The following list outlines potential reactions: Mild discomfort, bruising, or redness at the injection site Temporary bloating or abdominal cramping (more common with IV drips) Allergic reactions, including rash or itching, in rare cases Potential kidney stress at very high, prolonged doses administered without medical supervision Possible interactions with chemotherapy drugs patients undergoing cancer treatment should consult their oncologist Serious adverse effects are typically associated with unregulated products, improper dosing, or administration in non-medical settings
The FDA prescribing information for semaglutide and tirzepatide lists nausea, vomiting, diarrhea, constipation, and abdominal pain as frequent adverse reactions
Insulin functions as a direct intervention that lowers blood glucose levels by promoting the absorption of sugar into the bodys cells, crucial for both types of diabetes
Biological Information Family: GPCR Sub Family: Glucagon Class: Class B Protein Name: GLP-1 Uniprot Number: P43220 Protein Aliases: GLP-1-R|GLP-1R Gene Name: GLP1R Gene ID: 2740 Accession Number: NM_002062 Organism: Mouse Cell Type: Beta TC6 Assay Information Assay Type: Functional Assay Sub Type: Cell Based Functional Mode: Agonist Detection Method: HTRF Testing Information Incubation: 10 min at RT Control Activator: GLP-1(7-37) Test Concentration / Dose: Eurofins will provide IC/EC50 calculation if 5 or more concentrations are selected
Supply is only possible if treatment is clinically suitable